These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17338658)

  • 1. Metabolic modulation for cardiac protection.
    Weinberg GL; Massad MG
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):135-8. PubMed ID: 17338658
    [No Abstract]   [Full Text] [Related]  

  • 2. Is blood versus crystalloid cardioplegia relevant? Significantly improved protection may require new cardioplegic concepts!
    Fallouh HB; Chambers DJ
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1162-3. PubMed ID: 18784121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is blood cardioplegia superior to crystalloid cardioplegia in pediatric cardiac surgery?
    Raja SG
    Interact Cardiovasc Thorac Surg; 2008 May; 7(3):498-9. PubMed ID: 18495724
    [No Abstract]   [Full Text] [Related]  

  • 4. [Accelerated myocardial metabolic and functional recovery with terminal nicorandil-mg cardioplegia in experimental heart transplantation].
    Orita H; Kobayashi M; Shimanuki T; Fukasawa M; Abe H; Kuraoka S; Inui K; Washio M
    Nihon Kyobu Geka Gakkai Zasshi; 1988 Oct; 36(10):2188-93. PubMed ID: 2974855
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glucose-insulin-potassium (GIK) in the reduction of acute myocardial ischemia after an aortocoronary bypass intervention].
    Dainese L; Polvani GL; Fumero A; Spirito R; Alamanni F; Agrifoglio M; Parolari A; Biglioli P
    G Ital Cardiol; 1999 May; 29(5):575-9; discussion 580-2. PubMed ID: 10367228
    [No Abstract]   [Full Text] [Related]  

  • 6. [On metabolic therapeutics G-I-K in surgery of cardiac patients].
    de Micheli A; Medrano GA
    Arch Cardiol Mex; 2004; 74(3):215-9. PubMed ID: 15559874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study on myocardial protection with verapamil cardioplegia].
    Zhu P
    Zhonghua Yi Xue Za Zhi; 1988 Jun; 68(6):316-9, 22. PubMed ID: 3228722
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation.
    Sack MN; Yellon DM
    J Am Coll Cardiol; 2003 Apr; 41(8):1404-7. PubMed ID: 12706939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial protection of insulin and potassium in a porcine ischemia-reperfusion model.
    Oates A; Nubani R; Smiley J; Kistler L; Hughey S; Theiss P; Perez-Tamayo RA; Eiferman D; Lonchyna V; Higgins RS
    Surgery; 2009 Jul; 146(1):23-30. PubMed ID: 19541007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety limit of our myocardial protection method, and possibility of glutamate enriched asanguineous secondary cardioplegia].
    Shibata E; Andou F; Akagawa H; Yanagi I; Shima H; Yamashita M; Ouryouji A; Isomura T; Hara H; Kosuga K
    Rinsho Kyobu Geka; 1987; 7(1):37-9. PubMed ID: 9301754
    [No Abstract]   [Full Text] [Related]  

  • 11. Discussion.
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):947-8. PubMed ID: 23953719
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolic therapy with glucose-insulin-potassium. Historical outline].
    de Micheli A
    Arch Inst Cardiol Mex; 2000; 70(6):609-15. PubMed ID: 11255721
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric myocardial protection: where do we stand?
    Allen BS
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):11-3. PubMed ID: 15224014
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardioprotective effects of normothermic reperfusion with oxygenated potassium cardioplegia: a possible mechanism.
    Yamamoto H; Magishi K; Goh K; Sasajima T; Yamamoto F
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):598-604. PubMed ID: 19584068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic therapy in cardiac surgery--"Optimizing the engine's fuel supply and more...".
    Doenst T; Amorim PA
    Scand Cardiovasc J; 2010 Feb; 44(1):4-8. PubMed ID: 20141343
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial protection for cardiac surgery.
    Myers ML; Fremes SE
    EXS; 1996; 76():345-64. PubMed ID: 8805805
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative evaluation of clinical use of cardioplegic solutions custodiol and konsol in the correction of cardiac valvular diseases].
    Zhidkov IL; Kozhevnikov VA; Ivanov VA; Morozov IuA; Andrianova MIu; Van EIu; Trekova NA
    Anesteziol Reanimatol; 2006; (2):13-8. PubMed ID: 16758937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas' and histidine-tryptophan-ketoglutarate cardioplegia--an experimental comparative study in pigs.
    Aarsaether E; Stenberg TA; Jakobsen Ø; Busund R
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):635-9. PubMed ID: 19628529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of cytochrome c on the myocardium during reperfusion].
    Boiarinov GA; Iakovlev AIu; Teziaeva SA; Mukhina IV; Boiarinova LV
    Patol Fiziol Eksp Ter; 1999; (4):20-5. PubMed ID: 10598459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart.
    Grossman AN; Opie LH; Beshansky JR; Ingwall JS; Rackley CE; Selker HP
    Circulation; 2013 Mar; 127(9):1040-8. PubMed ID: 23459576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.